Testing THE-0504 in Advanced Solid Tumors
Part of Cancer, Digestive system, Lungs & breathing, Skin clinical trials.
This Phase 1 trial tests a new drug called THE-0504 in patients with advanced solid tumors (like lung, colon, pancreas, stomach, or breast cancer) that have not responded to standard treatments. The study aims to find the right dose and understand how well and safely the drug works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor (cancer in an organ) that is either spread to other parts of your body or cannot be surgically removed, and it has not responded to all available approved treatments
- Your overall health status allows you to carry out daily activities with minimal assistance (ECOG score 0 or 1)
- Your liver, kidney, and blood cell counts are working well enough to safely receive the study drug, as shown by recent lab tests
- You are at least 18 years old and able to attend all study visits and follow the trial requirements
- If you can have children, you agree to use effective birth control during the trial and for at least 12 months after the last study drug dose
- You have not had another cancer in the past 5 years (except for certain skin cancers or early cervical cancer that was treated)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SIM0505 for people with advanced solid tumors that have not responded to standard treatments. The study looks at different cancer types, including ovarian cancer, kidney cancer, uterine cancer, and lung cancer, to see if SIM0505 can help shrink tumors or slow their growth.
This study tests an experimental drug called CT3001 for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it's safe and effective, and for some patients with colorectal cancer, it may be combined with standard chemotherapy.
This trial is testing a new drug (HC010) for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe, how it works in the body, and whether it can shrink tumors.
This early-phase trial tests a new drug (CD-001) for people with advanced solid tumors. It will check if the drug is safe, how the body handles it, and if it helps shrink tumors.
This trial tests a new drug called FTL001 for people with advanced solid tumors that have not improved with standard therapy. The goal is to see if it is safe and how well it works.
This trial tests an investigational drug called FTL008.16 for people with advanced solid tumors that may carry a protein called 5T4. The main goal is to see if the drug is safe and tolerable.
Hear when a new Colorectal Carcinoma (CRC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.